Taro Announces T2007 Clinical Trials (OTC:TAROF)
Taro Announces T2007 Clinical Trials (OTC:TAROF)Enzon Sets Special Meeting of Stockholders (NASDAQ:ENZN)
Enzon Sets Special Meeting of Stockholders (NASDAQ:ENZN)Bullish Breakout Technical Alert (OTC:BZCN)
Bullish Breakout Technical Alert (OTC:BZCN)Enzo Biochem Signs Marketing Agreement (NYSE:ENZ)
Enzo Biochem Signs Marketing Agreement (NYSE:ENZ)GTx Announces Reduction in Workforce (NASDAQ:GTXI)
GTx Announces Reduction in Workforce (NASDAQ:GTXI)BioMimetic Ships Augment Bone Graft (NASDAQ:BMTI)
BioMimetic Ships Augment Bone Graft (NASDAQ:BMTI)Ameritrade restricts trading of BIEL and HTDS
Ameritrade restricts trading of BIEL and HTDSFero Industries' Growth Strategy (OTC:FROI)
Fero Industries' Growth Strategy (OTC:FROI)Medifocus Begins OTC Trading (OTC:MDFZE)
Medifocus Begins OTC Trading (OTC:MDFZE)Neoprobe Submits Phase 3 Data to FDA (OTC:NEOP)
Neoprobe Submits Phase 3 Data to FDA (OTC:NEOP)Quidel's Stock Repurchase Program (NASDAQ:QDEL)
Quidel's Stock Repurchase Program (NASDAQ:QDEL)Allos Provides New Folotyn Data (NASDAQ:ALTH)
Allos Provides New Folotyn Data (NASDAQ:ALTH)Facet Biotech Reports Elotuzumab Data (NASDAQ:FACT)
Facet Biotech Reports Elotuzumab Data (NASDAQ:FACT)Freeze Your Communication Costs
Freeze Your Communication CostsProvision to Revolutionize a Billion Dollar Market (OTC:PVHO)
Provision to Revolutionize a Billion Dollar Market (OTC:PVHO)Silenor Approaching FDA Decision Date (SOMX)
Silenor Approaching FDA Decision Date (SOMX)Simulations Plus' New Software Version (NASDAQ:SLP)
Simulations Plus' New Software Version (NASDAQ:SLP)Healthways' Fitness Program (NASDAQ:HWAY)
Healthways' Fitness Program (NASDAQ:HWAY)Cheerful Shoppers vs. Grumpy Accountants
Cheerful Shoppers vs. Grumpy AccountantsDyax approaching its PDUFA Date (DYAX)
Dyax approaching its PDUFA Date (DYAX)FDA Decision scheduled for Santarus (SNTS)
FDA Decision scheduled for Santarus (SNTS)Will the $20 million payment for VIBATIV pay off? (THRX, JNJ, ALPMF)
Will the $20 million payment for VIBATIV pay off? (THRX, JNJ, ALPMF)What You Need to Know about Home Equity Loans
What You Need to Know about Home Equity LoansImmunoGen's Second License to Amgen (IMGN, AMGN)
ImmunoGen's Second License to Amgen (IMGN, AMGN)CombinatoRx & Neuromed Merger at risk? (NASDAQ:CRXX)
CombinatoRx & Neuromed Merger at risk? (NASDAQ:CRXX)Sucampo Granted Marketing Authorization From FDA (NASDAQ:SCMP)
Sucampo Granted Marketing Authorization From FDA (NASDAQ:SCMP)Pay Day Loans: Life Saver or Death Trap?
Pay Day Loans: Life Saver or Death Trap?Power3 Investors Looking Forward to Expo (OTC:PWRM)
Power3 Investors Looking Forward to Expo (OTC:PWRM)ImmunoGen Announces IMGN901 Data (NASDAQ:IMGN)
ImmunoGen Announces IMGN901 Data (NASDAQ:IMGN)ImmunoGen Announces IMGN901 Data (NASDAQ:IMGN)
ImmunoGen Announces IMGN901 Data (NASDAQ:IMGN)
My Tags
- 11
- acrux
- adam
- addiction
- agendia
- allergan
- alliance
- alr
- alrt
- alth
- ambrx-wyeth
- ampligen
- analysis
- approval
- approves
- astrazeneca
- auxilium
- axiron
- basher
- biel
- biocryst
- bioelectronics
- bionovo
- biotech
- bnvi
- botox
- bristol-myers
- business
- cancer
- caraco
- card
- carter
- catalyst
- cervarix
- chapter
- chelsea
- chtp
- cmo
- companies
- compressors
- costs
- credit
- dapagliflozin
- dd
- debt
- discovery
- dr
- droxidopa
- drug
- dsco
- dupont
- eat
- energy
- fastest
- favorite
- fda
- feuerstein
- fico
- finance
- financing
- flu
- folotyn
- food
- fovea
- growing
- gsk
- heb
- hemispherx
- hepatitis
- hiv
- immunocellular
- imuc
- inc.
- introgen
- kr
- labs
- late
- limits
- lower
- magazine
- market
- mastercard
- n1h1
- nebulizer
- news
- nycomed
- on
- onlywire
- opko
- otc
- paid
- patent
- payments
- personal
- pharmaceutical
- pharmaceuticals
- proellex
- reduce
- repros
- sanofi-aventis
- save
- sbux
- score
- sny
- solvay
- spray
- stock
- stocks
- surfaxin
- swine
- swy
- technologies
- telaprevir
- testosterone
- therapeutic
- thestreet.com
- tscm
- u.s.
- vertex
- visa
- vxgn
- warning
- xiaflex

